CVS CVS Health
Data as of close
Consumer Defensive · Retail-Drug Stores And Proprietary Stores
CVS Health (CVS) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry, with a market capitalization of $117.3 billion. Shares last traded at $91.70, 17.1% below their 52-week high. Over the past year the stock is up 17.3%. CVS trades at a price-to-earnings ratio of 23.98, below the Retail-Drug Stores And Proprietary Stores median of 31.64. Net profit margin is 1.2%, above the peer median of -0.2%. Revenue grew 7.8% year over year. The shares yield 2.9% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
CVS Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $3.40B | $2.67 | 192% |
| 2024-12-31 | $3.37B | $2.67 | 73% |
| 2023-12-31 | $3.13B | $2.43 | 38% |
| 2022-12-31 | $2.91B | $2.20 | 67% |
| 2021-12-31 | $2.63B | $1.98 | 33% |
| 2020-12-31 | $2.62B | $2.00 | 37% |
| 2019-12-31 | $2.60B | $1.99 | 39% |
| 2018-12-31 | $2.04B | $1.95 | — |
| 2017-12-31 | $2.05B | $2.00 | 31% |
| 2016-12-31 | $1.84B | $1.71 | 35% |
| 2015-12-31 | $1.58B | $1.40 | 30% |
| 2014-12-31 | $1.29B | $1.10 | 28% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $2.31 | 2026-08-05 |
| Q1 2026 | $2.30 | 2026-05-06 |
| Q4 2025 (derived) | $2.31 | 2026-02-10 |
| FY 2025 | $1.39 | 2026-02-10 |
| Q3 2025 | -$3.13 | 2025-10-29 |
| Q2 2025 | $0.80 | 2025-07-31 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Retail-Drug Stores And Proprietary Stores peers
CVS vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap. Data as of close
🇨🇦 CVS Health also trades on Cboe Canada as a CAD-hedged Canadian Depositary Receipt (CDR) under CVS. A CDR represents the same underlying CVS shares in Canadian dollars with the currency exposure hedged; this page tracks the US-listed shares.
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.